Hind Ali Alkhatabi

6PUBLICATIONS
8CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Carbon sequestration science
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 22, 2026
Deciphering the Dysregulated Pathways and Candidate Therapeutic Compounds for Primary Ovarian Cancer Using Whole Transcriptomics Data and Next Generation Knowledge Discovery Strategies.

|May 13, 2026
Novel NSAID Analogs Exhibit Anti-Leukemic Activity Through Modulation of Apoptotic and Survival Pathways.

|Nov 13, 2025
Correction: Alzahrani et al. Propranolol and Capecitabine Synergy on Inducing Ferroptosis in Human Colorectal Cancer Cells: Potential Implications in Cancer Therapy. Cancers 2025, 17, 1470.

Shiekhah Mohammad Alzahrani, Huda Abdulaziz Al Doghaither, Hind Ali Alkhatabi

|Aug 14, 2025
Investigating the Potential of Propranolol as an Anti-Tumor Agent in Colorectal Cancer Cell Lines.

Shiekhah Mohammad Alzahrani, Huda Abdulaziz Al Doghaither, Hind Ali Alkhatabi

|May 14, 2025
Propranolol and Capecitabine Synergy on Inducing Ferroptosis in Human Colorectal Cancer Cells: Potential Implications in Cancer Therapy.

Shiekhah Mohammad Alzahrani, Huda Abdulaziz Al Doghaither, Hind Ali Alkhatabi

|Feb 13, 2025
In Silico Analysis of Temperature-Induced Structural, Stability, and Flexibility Modulations in Camel Cytochrome c.

Heba A Alkhatabi, Mohammad Alhashmi, Hind Ali Alkhatabi

Pageof 1

Frequent Collaborators

4 joint publications

Mohammed Basabrain

4 joint publications

Shiekhah Mohammad Alzahrani

3 joint publications

Peter Natesan Pushparaj

3 joint publications

Huda Abdulaziz Al Doghaither